# Dabigatran for Mitral Stenosis Atrial Fibrillation

> **NCT04045093** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 370 (estimated)

## Conditions studied

- Atrial Fibrillation
- Mitral Stenosis

## Interventions

- **DRUG:** Dabigatran etexilate
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT04045093
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-10-22
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 370 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04045093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04045093, "Dabigatran for Mitral Stenosis Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04045093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*